{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:43:15Z","timestamp":1784547795300,"version":"3.55.0"},"reference-count":34,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,1,29]]},"DOI":"10.1248\/bpb.b25-00678","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:08:46Z","timestamp":1769638126000},"page":"201-212","source":"Crossref","is-referenced-by-count":1,"title":["&lt;i&gt;In Vivo&lt;\/i&gt; and &lt;i&gt;in Vitro&lt;\/i&gt; Characterization of the Anti-inflammatory and Neuroprotective Effects of TPNA10168"],"prefix":"10.1248","volume":"49","author":[{"given":"Yasuhiko","family":"Izumi","sequence":"first","affiliation":[{"name":"Laboratory of Pharmacology, Kobe Pharmaceutical University, 4\u201319\u20131 Motoyamakita-machi, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Hirai","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Kobe Pharmaceutical University, 4\u201319\u20131 Motoyamakita-machi, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuka","family":"Moro","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Kobe Pharmaceutical University, 4\u201319\u20131 Motoyamakita-machi, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonoka","family":"Inoue","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Kobe Pharmaceutical University, 4\u201319\u20131 Motoyamakita-machi, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Nonaka","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Kobe Pharmaceutical University, 4\u201319\u20131 Motoyamakita-machi, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Ikawa","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Kobe Pharmaceutical University, 4\u201319\u20131 Motoyamakita-machi, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouya","family":"Yamaki","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Kobe Pharmaceutical University, 4\u201319\u20131 Motoyamakita-machi, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Takeda","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Kobe Pharmaceutical University, 4\u201319\u20131 Motoyamakita-machi, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yamada","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Kobe Pharmaceutical University, 4\u201319\u20131 Motoyamakita-machi, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Ueda","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Chemistry, Kobe Pharmaceutical University, 4\u201319\u20131 Motoyamakita-machi, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Kume","sequence":"additional","affiliation":[{"name":"Department of Applied Pharmacology, Graduate School of Medical and Pharmaceutical Science, University of Toyama, 2630 Sugitani, Toyama 930\u20130194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Koyama","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Kobe Pharmaceutical University, 4\u201319\u20131 Motoyamakita-machi, Higashinada-ku, Kobe 658\u20138558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) R\u00e9us GZ, Fries GR, Stertz L, Badawy M, Passos IC, Barichello T, Kapczinski F, Quevedo J. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. <i>Neuroscience<\/i>, <b>300<\/b>, 141\u2013154 (2015).","DOI":"10.1016\/j.neuroscience.2015.05.018"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Xu L, He D, Bai Y. Microglia-mediated inflammation and neurodegenerative disease. <i>Mol. Neurobiol.<\/i>, <b>53<\/b>, 6709\u20136715 (2016).","DOI":"10.1007\/s12035-015-9593-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Subhramanyam CS, Wang C, Hu Q, Dheen ST. Microglia-mediated neuroinflammation in neurodegenerative diseases. <i>Semin. Cell Dev. Biol.<\/i>, <b>94<\/b>, 112\u2013120 (2019).","DOI":"10.1016\/j.semcdb.2019.05.004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Tu W, Wang H, Li S, Liu Q, Sha H. The anti-inflammatory and anti-oxidant mechanisms of the Keap1\/Nrf2\/ARE signaling pathway in chronic diseases. <i>Aging Dis.<\/i>, <b>10<\/b>, 637\u2013651 (2019).","DOI":"10.14336\/AD.2018.0513"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Suzuki T, Yamamoto M. Molecular basis of the Keap1-Nrf2 system. <i>Free Radic. Biol. Med.<\/i>, <b>88<\/b><b> (<\/b>Pt. B<b>)<\/b>, 93\u2013100 (2015).","DOI":"10.1016\/j.freeradbiomed.2015.06.006"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Paraiso HC, Kuo PC, Curfman ET, Moon HJ, Sweazey RD, Yen JH, Chang FL, Yu IC. Dimethyl fumarate attenuates reactive microglia and long-term memory deficits following systemic immune challenge. <i>J. Neuroinflammation<\/i>, <b>15<\/b>, 100 (2018).","DOI":"10.1186\/s12974-018-1125-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Hiramatsu G, Uta D, Mihara K, Andoh T, Kume T. Inhibitory effect of panaxytriol on BV-2 microglial cell activation. <i>J. Pharmacol. Sci.<\/i>, <b>145<\/b>, 273\u2013278 (2021).","DOI":"10.1016\/j.jphs.2021.01.001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Gillard GO, Collette B, Anderson J, Chao J, Scannevin RH, Huss DJ, Fontenot JD. DMF, but not other fumarates, inhibits NF-\u03baB activity <i>in vitro<\/i> in an Nrf2-independent manner. <i>J. Neuroimmunol.<\/i>, <b>283<\/b>, 74\u201385 (2015).","DOI":"10.1016\/j.jneuroim.2015.04.006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Greaney AJ, Maier NK, Leppla SH, Moayeri M. Sulforaphane inhibits multiple inflammasomes through an Nrf2-independent mechanism. <i>J. Leukoc. Biol.<\/i>, <b>99<\/b>, 189\u2013199 (2016).","DOI":"10.1189\/jlb.3A0415-155RR"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yang H, Lv H, Li H, Ci X, Peng L. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-\u03baB pathways. <i>Cell Commun. Signal.<\/i>, <b>17<\/b>, 62 (2019).","DOI":"10.1186\/s12964-019-0366-y"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Schulze-Topphoff U, Varrin-Doyer M, Pekarek K, Spencer CM, Shetty A, Sagan SA, Cree BA, Sobel RA, Wipke BT, Steinman L, Scannevin RH, Zamvil SS. Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>113<\/b>, 4777\u20134782 (2016).","DOI":"10.1073\/pnas.1603907113"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Izumi Y, Kataoka H, Inose Y, Akaike A, Koyama Y, Kume T. Neuroprotective effect of an Nrf2-ARE activator identified from a chemical library on dopaminergic neurons. <i>Eur. J. Pharmacol.<\/i>, <b>818<\/b>, 470\u2013479 (2018).","DOI":"10.1016\/j.ejphar.2017.11.023"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Inose Y, Izumi Y, Takada-Takatori Y, Akaike A, Koyama Y, Kaneko S, Kume T. Protective effects of Nrf2-ARE activator on dopaminergic neuronal loss in Parkinson disease model mice: Possible involvement of heme oxygenase-1. <i>Neurosci. Lett.<\/i>, <b>736<\/b>, 135268 (2020).","DOI":"10.1016\/j.neulet.2020.135268"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Izumi Y, Tatsumoto A, Horiuchi N, Arifuku M, Uegomori M, Kume T, Koyama Y. TPNA10168, an Nrf-2 activator, attenuates inflammatory responses independently of Nrf-2 in microglial BV-2 cells: Involvement of the extracellular-signal-regulated kinase pathway. <i>J. Pharmacol. Sci.<\/i>, <b>149<\/b>, 1\u201310 (2022).","DOI":"10.1016\/j.jphs.2022.02.004"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Izumi Y, Koide E, Kobayashi F, Ikawa S, Takayama M, Yamaki K, Takeda N, Yamada T, Ueda M, Kume T, Koyama Y. TPNA10168, an Nrf2 activator, attenuates LPS-induced inflammation in microglia through modulation of MAPK and NF-\u03baB pathways. <i>J. Pharmacol. Sci.<\/i>, <b>159<\/b>, 35\u201343 (2025).","DOI":"10.1016\/j.jphs.2025.07.001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. <i>Glia<\/i>, <b>55<\/b>, 453\u2013462 (2007).","DOI":"10.1002\/glia.20467"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Huang R, Gao Y, Chen J, Duan Q, He P, Zhang J, Huang H, Zhang Q, Ma G, Zhang Y, Nie K, Wang L. TGR5 agonist INT-777 alleviates inflammatory neurodegeneration in Parkinson\u2019s disease mouse model by modulating mitochondrial dynamics in microglia. <i>Neuroscience<\/i>, <b>490<\/b>, 100\u2013119 (2022).","DOI":"10.1016\/j.neuroscience.2022.02.028"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Bourin M, Hasco\u00ebt M. The mouse light\/dark box test. <i>Eur. J. Pharmacol.<\/i>, <b>463<\/b>, 55\u201365 (2003).","DOI":"10.1016\/S0014-2999(03)01274-3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Gupta GL, Fernandes J. Protective effect of <i>Convolvulus pluricaulis<\/i> against neuroinflammation associated depressive behavior induced by chronic unpredictable mild stress in rat. <i>Biomed. Pharmacother.<\/i>, <b>109<\/b>, 1698\u20131708 (2019).","DOI":"10.1016\/j.biopha.2018.11.046"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Izumi Y, Ikawa S, Yamaki K, Kume T, Koyama Y. Evaluation of the deep learning-based detection of dopaminergic neurons in primary culture: a practical alternative to manual counting. <i>J. Neurosci. Methods<\/i>, <b>423<\/b>, 110557 (2025).","DOI":"10.1016\/j.jneumeth.2025.110557"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Choi HB, Ryu JK, Kim SU, McLarnon JG. Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain. <i>J. Neurosci.<\/i>, <b>27<\/b>, 4957\u20134968 (2007).","DOI":"10.1523\/JNEUROSCI.5417-06.2007"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Yan M, Bo X, Zhang J, Liu S, Li X, Liao Y, Liu Q, Cheng Y, Cheng J. Bergapten alleviates depression-like behavior by inhibiting cyclooxygenase 2 activity and NF-\u03baB\/MAPK signaling pathway in microglia. <i>Exp. Neurol.<\/i>, <b>365<\/b>, 114426 (2023).","DOI":"10.1016\/j.expneurol.2023.114426"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kawamura A, Sawamoto A, Okuyama S, Nakajima M. Cloperastine reduces IL-6 expression <i>via<\/i> Akt\/GSK3\/Nrf2 signaling in monocytes\/macrophages and ameliorates symptoms in a mouse sepsis model induced by lipopolysaccharide. <i>Biol. Pharm. Bull.<\/i>, <b>47<\/b>, 1699\u20131707 (2024).","DOI":"10.1248\/bpb.b24-00472"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Shibata H, Katsuki H, Nishiwaki M, Kume T, Kaneko S, Akaike A. Lipopolysaccharide-induced dopaminergic cell death in rat midbrain slice cultures: Role of inducible nitric oxide synthase and protection by indomethacin. <i>J. Neurochem.<\/i>, <b>86<\/b>, 1201\u20131212 (2003).","DOI":"10.1046\/j.1471-4159.2003.01929.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Jeong HK, Jou I, Joe EH. Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra. <i>Exp. Mol. Med.<\/i>, <b>42<\/b>, 823\u2013832 (2010).","DOI":"10.3858\/emm.2010.42.12.085"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Nusse Y, Kubes P. Liver macrophages: development, dynamics, and functions. <i>Cell. Mol. Immunol.<\/i>, <b>22<\/b>, 1178\u20131189 (2025).","DOI":"10.1038\/s41423-025-01298-3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Norden DM, Trojanowski PJ, Villanueva E, Navarro E, Godbout JP. Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge. <i>Glia<\/i>, <b>64<\/b>, 300\u2013316 (2016).","DOI":"10.1002\/glia.22930"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Nadeau S, Rivest S. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: A view from the blood-brain barrier. <i>Neuroscience<\/i>, <b>93<\/b>, 1449\u20131464 (1999).","DOI":"10.1016\/S0306-4522(99)00225-0"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Singh AK, Jiang Y. How does peripheral lipopolysaccharide induce gene expression in the brain of rats? <i>Toxicology<\/i>, <b>201<\/b>, 197\u2013207 (2004).","DOI":"10.1016\/j.tox.2004.04.015"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Skelly DT, Hennessy E, Dansereau MA, Cunningham C. A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1\u03b2, TNF-\u03b1 and IL-6 challenges in C57BL\/6 mice. <i>PLOS ONE<\/i>, <b>8<\/b>, e69123 (2013).","DOI":"10.1371\/journal.pone.0069123"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Noh H, Jeon J, Seo H. Systemic injection of LPS induces region-specific neuroinflammation and mitochondrial dysfunction in normal mouse brain. <i>Neurochem. Int.<\/i>, <b>69<\/b>, 35\u201340 (2014).","DOI":"10.1016\/j.neuint.2014.02.008"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Lay\u00e9 S, Gheusi G, Cremona S, Combe C, Kelley K, Dantzer R, Parnet P. Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. <i>Am. J. Physiol. Regul. Integr. Comp. Physiol.<\/i>, <b>279<\/b>, R93\u2013R98 (2000).","DOI":"10.1152\/ajpregu.2000.279.1.R93"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Bluth\u00e9 RM, Lay\u00e9 S, Michaud B, Combe C, Dantzer R, Parnet P. Role of interleukin-1\u03b2 and tumour necrosis factor-\u03b1 in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. <i>Eur. J. Neurosci.<\/i>, <b>12<\/b>, 4447\u20134456 (2000).","DOI":"10.1111\/j.1460-9568.2000.01348.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Bonsall DR, Kim H, Tocci C, Ndiaye A, Petronzio A, McKay-Corkum G, Molyneux PC, Scammell TE, Harrington ME. Suppression of locomotor activity in female C57Bl\/6J mice treated with interleukin-1\u03b2: Investigating a method for the study of fatigue in laboratory animals. <i>PLOS ONE<\/i>, <b>10<\/b>, e0140678 (2015).","DOI":"10.1371\/journal.pone.0140678"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/1\/49_b25-00678\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T03:28:38Z","timestamp":1769830118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/1\/49_b25-00678\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00678","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"article-number":"b25-00678"}}